cbdMD, Inc. — Form 8-K
Filed November 4, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 78/100
What the filing says
cbdMD acquired operating assets of Twinlab, Reserveage, Metabolife, and ResVitale brands through bankruptcy proceedings, financed by a $1.75M senior secured promissory note from Akretive Holdings (9% interest, 2-year maturity, escalating to 18% if unpaid). To Be Brands LLC, cbdMD's acquisition subsidiary, serves as borrower with collateral comprising equity in four subsidiaries and substantially all company assets. Transaction completed October 27, 2026; press release dated November 2, 2026. Twinlab will provide transition services for up to 15 hours at no cost, then at agreed rates.
Why this rating
Material acquisition—debt equals 62% of $2.8M market cap. Diversifies hemp-dependent company into established supplement brands (decades-old Twinlab, former billion-dollar Metabolife). Refinances via secured debt; significant integration risk and regulatory/execution uncertainty.
Price action (we called it positive)
before filing · preread $0.41 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.